PT - JOURNAL ARTICLE AU - Ghasemi, Amir AU - Daneman, Nick AU - Berry, Isha AU - Buchan, Sarah A. AU - Soucy, Jean-Paul AU - Sturrock, Shelby AU - Brown, Kevin A. TI - Impact of a nighttime curfew on overnight mobility AID - 10.1101/2021.04.04.21254906 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.04.21254906 4099 - http://medrxiv.org/content/early/2021/04/07/2021.04.04.21254906.short 4100 - http://medrxiv.org/content/early/2021/04/07/2021.04.04.21254906.full AB - Background Among non-pharmaceutical interventions, individual movement restrictions have been among the most impactful methods for controlling COVID-19 case growth. While nighttime curfews to control COVID-19 case growth have been implemented in certain regions and cities, few studies have examined their impacts on mobility or COVID-19 incidence. In the second wave of COVID-19, Canada’s two largest and adjacent provinces implemented lockdown restrictions with (Quebec) and without (Ontario) a nighttime curfew, providing a natural experiment to study the association between curfews and mobility.Methods This study spanned from December 1, 2020 to January 23, 2021 and included the populations of Ontario (including Toronto) and Quebec (including Montreal). The intervention of interest was a nighttime curfew implemented across Quebec on January 9, 2021. Unadjusted and adjusted difference-in-differences models (DID) were used to measure the incremental impact of the curfew on nighttime mobility in Quebec as compared to Ontario.Results The implementation of the curfew was associated with an immediate reduction in nighttime mobility. The adjusted DID analysis indicated that Quebec experienced a 31% relative reduction in nighttime mobility (95%CI: -36% to -25%) compared to Ontario, and that Montreal experienced a 39% relative reduction compared to Toronto (95%CI: -43, -34).Discussion However, this natural experiment among two neighbouring provinces provides useful evidence that curfews lead to an immediate and substantial decrease nighttime mobility, particularly in these provinces’ largest urban areas hardest hit by COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received no external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was obtained from the University of Toronto Research Ethics Board through the Modeling Consensus Table, a provincial working group developing evidence for the COVID-19 response that operates with the support of the Ontario Ministry of Health, Ontario Health, and Public Health Ontario.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAggregated province-level and city-level data used for the analysis are available upon request.